Nidek Co., Ltd.

The ophthalmic equipment manufacturer donates cameras and awards financial support to the global eye care nonprofit's Vietnam program over the next three years. NEW YORK, Jan. 16, 2024 /PRNewswire/ -- Orbis International announces an important in-kind and financial donation from NIDEK to support Orbis's artificial intelligence (AI)-based screening services in Vietnam. The donation of six specialized fundus cameras, which take images of the retina (back of the eye), will support the scale up of Orbis' AI-based diabetic retinopathy screening program in Vietnam. These cameras are expected to support the screening of 72,000 patients with diabetes over the next three years. Continue Reading Dr. Hieu uses Orbis’s Cybersight AI platform to detect diabetic retinopathy and other blinding eye diseases at My Tho district health center in Vietnam. Photo: Orbis International The addition of the NIDEK cameras to Orbis's program will expand its presence to six high-volume screening health facilities in three provinces across Vietnam – including Giao Thuy District Health Center and Nam Dinh General Hospital in Nam Dinh province, Nghe An Endocrinology Hospital and Tay Bac Regional Hospital in Nghe An province and Can Tho General Hospital and Can Tho Heart Hospital in Can Tho city – improving capacity to detect and promptly treat diabetic retinopathy, a potentially blinding disease that every person with diabetes is at risk of developing. Images from NIDEK's superior desktop fundus cameras will be uploaded to and graded by Cybersight AI, Orbis's state-of-the-art technology, determining within seconds if diabetic retinopathy is detected. This allows patients the opportunity to be referred immediately for treatment, without first waiting days or even weeks for screening results that rely on human grading of the images. "According to the Vietnam National Endocrinology Hospital, in the past 20 years, the prevalence of diabetes in the country has increased from 2.7% of the population to 7.3% of the population, and this trend continues to grow," said Ngoc Pham, Country Director, Orbis Vietnam. "There are not enough trained medical professionals to meet the demand for eye screening for people living with diabetes. Cybersight AI and high-quality cameras will help ease the burden on medical facilities already at capacity by detecting diabetic retinopathy." "We are excited and confident that our partnership with Orbis and technological collaboration with their Cybersight AI, will certainly improve the diabetic retinopathy screening situation in Vietnam." says Motoki Ozawa, President and CEO of NIDEK CO., LTD. "Our purpose is to provide the joy of vision and health care through our technology and deliver unwavering commitment to people all over the world. We are committed to deliver joy of vision to people in Vietnam by supporting early detection and immediate referrals". Diabetic retinopathy is an eye disease that effects approximately one in three people living with diabetes. If left untreated, it can lead to vision loss and blindness. Most people living with diabetes reside in low- and middle-income countries, like Vietnam. Vietnam has approximately 7 million people with diabetes, and diabetic retinopathy is one of the leading causes of blindness and vision loss in the country. About Orbis Orbis is an international nonprofit delivering sight-saving programs in over 200 countries and regions worldwide so that individuals, families, and communities can thrive. Currently, around 1 billion people across the globe live with completely avoidable blindness and vision loss. For over four decades, Orbis has been tackling this challenge by building strong and sustainable eye care systems that leave a lasting legacy of vision. Orbis runs dedicated in-country programs in Africa, Asia, the Caribbean, and Latin America; develops and implements innovative training and technology, including an award-winning telemedicine and e-learning platform, Cybersight; and operates the world's first and only Flying Eye Hospital, a fully accredited ophthalmic teaching hospital on board an MD-10 aircraft. For the past ten consecutive years, Orbis has achieved Charity Navigator's coveted four-star rating for demonstrating strong financial health and commitment to accountability and transparency, placing Orbis in the top 3% of U.S. charities. For the past two years, Orbis has earned GuideStar's platinum Seal of Transparency. In 2022, Orbis earned "accredited charity" status from the Better Business Bureau by meeting all 20 of their standards for charity accountability. To learn more, please visit orbis.org. About NIDEK NIDEK CO., LTD., is a global leader in the design, manufacture, and distribution of ophthalmic, optometric, and lens edging equipment. Due to their technological expertise in combing optical and electronic technologies, the company has been at the forefront of ophthalmic innovation, creating industry leading products. MEDIA CONTACT Orbis International Jenna Montgomery Manager, Global Communications and Marketing [email protected] NIDEK CO., LTD. Secretariat & Public Relations [email protected] SOURCE Orbis International

DUBLIN, July 17, 2023 /PRNewswire/ -- The "Nonmydriatic Handheld Fundus Cameras: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Nonmydriatic Handheld Fundus Cameras estimated at US$138.5 Million in the year 2022, is projected to reach a revised size of US$259 Million by 2030, growing at a CAGR of 8.1% over the analysis period 2022-2030. Ophthalmology Clinics, one of the segments analyzed in the report, is projected to record a 8.5% CAGR and reach US$159.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hospitals segment is readjusted to a revised 7.9% CAGR for the next 8-year period. The U.S. Market is Estimated at $41.8 Million, While China is Forecast to Grow at 9.4% CAGR The Nonmydriatic Handheld Fundus Cameras market in the U.S. is estimated at US$41.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$30.3 Million by the year 2030 trailing a CAGR of 9.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 7.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR. Select Competitors (Total 46 Featured) - Canon, Inc. Carl Zeiss Meditec AG Kowa Company Ltd. NIDEK Co., Ltd. Optomed Oy (Ltd.) Optovue Incorporated Topcon Corporation Veatch Ophthalmic Instruments Key Topics Covered: I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Retinal Diseases and Fundus Cameras An Introduction to Nonmydriatic Handheld Fundus Cameras Non-Mydriatic Fundus Cameras Outshine Mydriatic Cameras for Ophthalmology Competition Nonmydriatic Handheld Fundus Cameras - Global Key Competitors Percentage Market Share in 2022 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) Impact of COVID-19 Pandemic and Looming Global Recession World Shifts to an Endemic COVID-19 Strategy with Focus on Multilateral Approach to Managing Future Pandemics War, Inflation & High Cost of Living Crisis Supersede COVID-19 as Major Downside Risks for the Global Economy in 2022 & Beyond World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020, 2021, 2022 and 2023 COVID-19 Leaves Non-Mydriatic Handheld Fundus Cameras Market with a Black Eye, Market Makes Strong Gains in 2021 & 2022 As Telehealth Makes Rapid Gains, Handheld Nonmydriatic Fundus Camera Emerge as a Vital Tool Global Market Prospects & Outlook Non-Mydriatic Fundus Cameras Market to See Brighter Days Ahead with Robust Demand Drivers Creating Perfect Landscape for Non-Mydriatic Fundus Cameras Market Portability Aspect of Non-Mydriatic Handheld Fundus Cameras Drives Market Growth Developed Regions Lead - North America as Star Region of Global Non-Mydriatic Fundus Cameras Market, Developing Economies to Fuel Future Growth Select Portable Fundus Cameras: Recent Market Activity 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS Rise in Prevalence of Eye Disorders Present Favorable Outlook for Nonmydriatic Portable Fundus Cameras Key Ophthalmic Disease Statistics Global Burden of Eye Diseases (In Millions): 2020 Prevalence of Adult Vision Impairment and Age-Related Eye Diseases in the US Global Causes of Visual Impairment: Percentage Breakdown by Number of Cases Portable Nonmydriatic Fundus Cameras Emerge as Effective Screening Tool for Retinal Diseases Aging Global Population & Rising Prevalence of Chronic Medical Conditions Lead to an Increase in Incidence Eye Disorders, Driving Market Gains Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030 Growing Diabetic Population and Increasing Risk of Diabetic Retinopathy to Fuel Need for Ophthalmic Screening Devices, Benefiting Market Growth World Diabetes and Population Statistics (2019, 2030 & 2045) World Diabetes Prevalence (2000-2045P) Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045 Age-Related Macular Degeneration (AMD): A Major Vision Disorder Presenting Opportunities for Fundus Cameras Market Global Population with Age-Related Macular Degeneration: 2016-2030 Glaucoma Prevalence and Need for Screening to Fuel Sales of Nonmydriatic Fundus Cameras Global Population with Glaucoma: 2016-2030 Handheld Non-Mydriatic Fundus Cameras Effective in Glaucoma Detection Vs Table-Top Fundus Camera Leading Models of Portable Fundus Cameras for Screening Glaucoma Non-Ophthalmological Uses of Nonmydriatic Fundus Imaging to Boost Market Technological Advancements to Spearhead Future Market Growth A Novel Non-Mydriatic Portable Fundus Imaging Solution Emerges Smartphone-Based Fundus Cameras Portable Smartphone-Based fundus Camera for Diabetic Retinopathy Screening: Comparison of Select Devices AI-based Non-Mydriatic Handheld Fundus Cameras: A Leap Forward for Eye Screening Rise of AI-Powered Non-Mydriatic Handheld Devices AI Comes to the Aid for Effective and Faster Screening and Diagnosis of Diabetic Retinopathy Using Fundus Imaging Rising Healthcare Spending and Focus on Quality & Affordable Care Delivery to Boost Market Prospects World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023 Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050 4. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITION For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

DUBLIN--( BUSINESS WIRE )--The "Ophthalmic Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. In recent years there have been significant advances in the development of ophthalmic devices and surgical procedures that have helped to improve diagnosis and treatment of a broad range of ophthalmic conditions, including cataracts, glaucoma, refractory and retinal disorders. The growth is being driven by the launch of new biocompatible materials, improvements in clinical optics and the launch of high-end surgical devices. Advancements in cataract and refractory surgery devices have also resulted in the improved safety and efficacy of routine procedures, helping to improve surgical outcomes, reduce perioperative morbidity and increase the number of patients willing to undergo surgery. The global ophthalmology device market is being driven by patient demographics such as the rising incidence of diabetes and obesity and the increasing geriatric population, which is increasing the number of patients with conditions such as age-related macular degeneration, cataracts, diabetic retinopathy and glaucoma, and helping to expand the addressable patient population in need of ophthalmic devices. In addition, market growth is being aided by growing awareness and early detection and monitoring of ocular disease, the rise in adoption of minimally invasive surgeries in Asia-Pacific, greater healthcare insurance coverage in Europe and positive reimbursement of ocular devices and surgical procedures in the United States. The market is dominated by a few players: EssilorLuxottica, Alcon, Bausch & Lomb, Carl Zeiss Meditec, CooperVision, Johnson & Johnson, Nidek, Topcon Corp. and Hoya Vision Care. Innovative new companies such as EyeKon Medical, Glaukos Corp.,Optos and others, are gradually making headway in the market. Within the market, EssilorLuxottica is the dominant player. Growth in this market has been driven by the innovations in eyeglasses and biocompatible materials encompassing silicone hydrogels, hydrogels and newly emerging hybrid materials, all of which are designed to improve contact lens safety and comfort. Report Includes 50 data tables and 13 additional tables A detailed overview and up-to-date analysis of the global markets for ophthalmic devices and related technologies Analyses of the global and regional market trends, with data for 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027 Discussion of the industry growth driving factors and challenges that will shape the market for ophthalmic devices as a basis for projecting demand over the next few years (2022-2027) Estimation of the actual market size and revenue forecast for global ophthalmic devices market in USD millions, and corresponding market share analysis by technology type, application, and region Analysis of the recent advances in contact lenses, cataract surgery, implantation ophthalmic devices, and complex medical surgeries; and their potential impact on diagnosis of prevalent eye conditions and improved healthcare solutions In-depth information (facts and figures) concerning major market dynamics, technology updates, latest developments, industry regulations, and other macroeconomic forces affecting the present and future market outlook Assessment of the recent industry structure, ongoing research activities, analysis of competitive environment, and COVID-19 effects on the ophthalmic devices market ecosystem Patent review and analysis of patent grants on ophthalmic device technologies Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues Market Dynamics Drivers Aging Population with Growing Eye Care Needs Technological Advancements Increasing Government Initiatives Increasing Wealth and Growth from Emerging Economics Increasing Prevalence of Vision Impairment Barriers High Cost and Risk Associated with Eye Surgery Lack of Skilled Professionals Accessibility, Acceptability Opportunities Growing Aging Population and Rising Demand for Vision Care Use of Mobile-Based and Artificial Intelligence Technologies Company Profiles Alcon Bausch + Lomb Inc. Bio-Tissue Inc. Coopervision Dutch Ophthalmic Research Center International Bv Ellex Medical Lasers Essilorluxottica Eyenuk Inc. Glaukos Heidelberg Engineering Gmbh Hoya Corp. Ioptima Ltd. Iridex Corp. Johnson & Johnson Lenstec Inc. Lumenis Nidek Co. Ltd. Oasis Medical Inc. Quantel Medical Sav-Iol Sa Shanghai Haohai Biological Technology Co. Ltd. Sight Sciences Inc. Softcare Solution Inc. Staar Surgical Tearscience Inc. Topcon Vasoptic Medical Inc. Zeiss Group Ziemer Ophthalmic Systems Ag For more information about this report visit https://www.researchandmarkets.com/r/g6jub5 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.